Adrenomedullin in COVID-19 induced endotheliitis.
作者信息
Wilson Darius Cameron, Schefold Joerg C, Baldirà Jaume, Spinetti Thibaud, Saeed Kordo, Elke Gunnar
机构信息
Shock, Organ Dysfunction and Resuscitation Research Group, Vall d'Hebron Institut of Research, Barcelona, Spain.
Department of Intensive Care Medicine, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland.
出版信息
Crit Care. 2020 Jul 9;24(1):411. doi: 10.1186/s13054-020-03151-7.
Abstract
摘要
相似文献
1
Adrenomedullin in COVID-19 induced endotheliitis.
Crit Care. 2020 Jul 9;24(1):411. doi: 10.1186/s13054-020-03151-7.
2
Corticosteroids and the hyper-inflammatory phase of the COVID-19 disease.
J Clin Anesth. 2020 Nov;66:109926. doi: 10.1016/j.jclinane.2020.109926. Epub 2020 May 26.
3
Would ACEIs/ARBs be beneficial for COVID-19 patients without hypertension?
Pharmacol Res. 2020 Sep;159:104959. doi: 10.1016/j.phrs.2020.104959. Epub 2020 Jun 4.
4
COVID-19 and the Heart.
Circ Res. 2020 May 8;126(10):1443-1455. doi: 10.1161/CIRCRESAHA.120.317055. Epub 2020 Apr 7.
5
Why obesity worsens COVID-19.
Science. 2020 Sep 11;369(6509):1280-1281. doi: 10.1126/science.369.6509.1280.
6
Narcolepsy and COVID-19: sleeping on an opportunity?
J Clin Sleep Med. 2020 Aug 15;16(8):1415. doi: 10.5664/jcsm.8520.
7
Report of a patient with neurological symptoms as the sole manifestation of SARS-CoV-2 infection.
Neurologia (Engl Ed). 2020 May;35(4):271-272. doi: 10.1016/j.nrl.2020.04.010. Epub 2020 Apr 24.
8
Happy Hypoxemia in COVID-19-A Neural Hypothesis.
ACS Chem Neurosci. 2020 Jul 1;11(13):1865-1867. doi: 10.1021/acschemneuro.0c00318. Epub 2020 Jun 12.
9
Multilead QT Screening Is Necessary for QT Measurement: Implications for Management of Patients in the COVID-19 Era.
JACC Clin Electrophysiol. 2020 Jul;6(7):878-880. doi: 10.1016/j.jacep.2020.04.001. Epub 2020 Apr 7.
10
Letter to editor: Severe brain haemorrhage and concomitant COVID-19 Infection: A neurovascular complication of COVID-19.
Brain Behav Immun. 2020 Jul;87:150-151. doi: 10.1016/j.bbi.2020.05.015. Epub 2020 May 5.
引用本文的文献
1
Mid-Regional Proadrenomedullin Can Be Reliably Measured in Cerebrospinal Fluid to Improve Diagnosis of Central Nervous System Diseases.
J Clin Lab Anal. 2025 Jul;39(13):e70058. doi: 10.1002/jcla.70058. Epub 2025 May 19.
2
A Focus on the Pathophysiology of Adrenomedullin Expression: Endothelitis and Organ Damage in Severe Viral and Bacterial Infections.
Cells. 2024 May 22;13(11):892. doi: 10.3390/cells13110892.
3
The Role of SARS-CoV-2 Nucleocapsidic Antigen and Krebs von den Lungen 6 Serum Levels in Predicting COVID-19 Pneumonia Outcome.
Diagnostics (Basel). 2024 Mar 18;14(6):642. doi: 10.3390/diagnostics14060642.
4
Comprehensive Assessment of Mid-Regional Proadrenomedullin, Procalcitonin, Neuron-Specific Enolase and Protein S100 for Predicting Pediatric Severe Trauma Outcomes.
Biomedicines. 2023 Aug 19;11(8):2306. doi: 10.3390/biomedicines11082306.
5
Synergistic effect of myocardial injury and mid-regional proAdrenomedullin elevation in determining clinical outcomes of SARS-CoV-2 patients.
Front Med (Lausanne). 2022 Oct 26;9:929408. doi: 10.3389/fmed.2022.929408. eCollection 2022.
6
Mid-regional Proadrenomedullin Biomarker Predicts Coronavirus Disease 2019 Clinical Outcomes: A US-Based Cohort Study.
Open Forum Infect Dis. 2022 Aug 24;9(9):ofac423. doi: 10.1093/ofid/ofac423. eCollection 2022 Sep.
7
Identification of COVID-19 patients at risk of hospital admission and mortality: a European multicentre retrospective analysis of mid-regional pro-adrenomedullin.
Respir Res. 2022 Aug 28;23(1):221. doi: 10.1186/s12931-022-02151-1.
8
Proadrenomedullin in the Management of COVID-19 Critically Ill Patients in Intensive Care Unit: A Systematic Review and Meta-Analysis of Evidence and Uncertainties in Existing Literature.
J Clin Med. 2022 Aug 4;11(15):4543. doi: 10.3390/jcm11154543.
9
Mid-regional proadrenomedullin, C-terminal proendothelin-1 values, and disease course are not different in critically ill SARS-CoV-2 pneumonia patients with obesity.
Int J Obes (Lond). 2022 Oct;46(10):1801-1807. doi: 10.1038/s41366-022-01184-2. Epub 2022 Jul 15.
10
Adrenomedullin Therapy in Moderate to Severe COVID-19.
Biomedicines. 2022 Feb 24;10(3):533. doi: 10.3390/biomedicines10030533.
本文引用的文献
1
Endothelial cell infection and endotheliitis in COVID-19.
Lancet. 2020 May 2;395(10234):1417-1418. doi: 10.1016/S0140-6736(20)30937-5. Epub 2020 Apr 21.
2
Biomarkers and clinical scores to identify patient populations at risk of delayed antibiotic administration or intensive care admission.
Crit Care. 2019 Oct 29;23(1):335. doi: 10.1186/s13054-019-2613-4.
3
The early identification of disease progression in patients with suspected infection presenting to the emergency department: a multi-centre derivation and validation study.
Crit Care. 2019 Feb 8;23(1):40. doi: 10.1186/s13054-019-2329-5.
4
The use of mid-regional proadrenomedullin to identify disease severity and treatment response to sepsis - a secondary analysis of a large randomised controlled trial.
Crit Care. 2018 Mar 21;22(1):79. doi: 10.1186/s13054-018-2001-5.
5
Adrenomedullin surges are linked to acute episodes of the systemic capillary leak syndrome (Clarkson disease).
J Leukoc Biol. 2018 Apr;103(4):749-759. doi: 10.1002/JLB.5A0817-324R. Epub 2018 Jan 23.
Zotero 插件